Automated Measurement of Salivary Cortisol , Maarten

References 1. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163–75. 2. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen GQ, et al. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 2000;106:R69–R73. 3. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, Walker M, et al. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 2001;69:544–52. 4. Orho-Melander M, Klannemark M, Svensson MK, Ridderstrale M, Lindgren CM, Groop L. Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 2002;51:2658–64. 5. Malecki MT, Moczulski DK, Klupa T, Wanic K, Cyganek K, Frey J, et al. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur J Endocrinol 2002;146: 695–9. 6. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, Cox NJ, et al. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002;87:650–4. 7. Garant MJ, Kao WH, Brancati F, Coresh J, Rami TM, Hanis CL, et al. SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 2002;51:231–7. 8. Sun HX, Zhang KX, Du WN, Shi JX, Jiang ZW, Sun H, et al. Single nucleotide polymorphisms in CAPN10 gene of Chinese people and its correlation with type 2 diabetes mellitus in Han people of northern China. Biomed Environ Sci 2002;15:75–82. 9. Tsai HJ, Sun G, Weeks DE, Kaushal R, Wolujewicz M, McGarvey ST, et al. Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am J Hum Genet 2001;69:1236–44. 10. Hegele RA, Harris SB, Zinman B, Hanley AJ, Cao H. Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree. Diabetes Care 2001;24:1498–9. 11. Rasmussen SK, Urhammer SA, Berglund L, Jensen JN, Hansen L, Echwald SM, et al. Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 2002;51:3561–7. 12. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, Mohlke KL, et al. Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 2002;51:1644–8. 13. Lay MJ, Wittwer CT. Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. Clin Chem 1997;43:2262–7. 14. de la Fuente M, Quinteiro C, Dominguez F, Loidi L. LightCycler PCR assay for genotyping codon 634 mutations in the RET protooncogene. Clin Chem 2001;47:1131–2. 15. Bernard PS, Wittwer CT. Homogeneous amplification and variant detection by fluorescent hybridization probes. Clin Chem 2000;46:147–8. 16. Loeffler J, Hagmeyer L, Hebart H, Henke N, Schumacher U, Einsele H. Rapid detection of point mutations by fluorescence resonance energy transfer and probe melting curves in Candida species. Clin Chem 2000;46:631–5. 17. Lyondagger E, Millsondagger A, Phan T, Wittwer CT. Detection and identification of base alterations within the region of factor V Leiden by fluorescent melting curves. Mol Diagn 1998;3:203–9. 18. Fullerton SM, Bartoszewicz A, Ybazeta G, Horikawa Y, Bell GI, Kidd KK, et al. Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus. Am J Hum Genet 2002;70:1096–106. Automated Measurement of Salivary Cortisol, Maarten O. van Aken, Johannes A. Romijn, Johannes A. Miltenburg, and Eef G.W.M. Lentjes ( Department of Endocrinology and Metabolic Diseases and 2 Laboratory of Clinical Chemistry, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands; 3 Endocrinology Laboratory, University Medical Center Utrecht, Postbox 85090, 3508 AB Utrecht, The Netherlands; * address correspondence to this author at: Department of Endocrinology and Metabolic Diseases, C4R, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; fax 00-31-715248136, e-mail m.o.van_aken@ lumc.nl)